Summary:
A randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of a study drug and placebo given orally for 12 weeks for the treatment of opioid-induced constipation in patients with chronic non-cancer pain.
Qualified Participants Must:
• Be Male or female
•
Be 50 years old or older
•
Have opioid induced constipation.
Qualified Participants May Receive:
$240.00 if you finish the whole study or $40.00 for each visit completed.